Shaemus Gleason Appointed Executive Vice President US Operations at Clarity Pharmaceuticals
- Written by PR Newswire
SYDNEY, May 11, 2021 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Shaemus Gleason as Executive Vice President U.S. Operations as the company expands its presence, clinical trials, and operations in the U.S.
Shaemus joins...